Clinical Trial Update: Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple Sclerosis

View source ↗

Summary

A clinical trial by Amsterdam UMC is validating digital biomarkers to detect disease activity and progression in multiple sclerosis. The study is currently not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Multiple Sclerosis | Status: NOT_YET_RECRUITING